23 /100
LOW RISK
Score updated Jul 13, 2026

NUS — Nu Skin Enterprises, Inc. Dilution Risk Tracker

Track NUS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NUS — Get alerts when the score changes →

As of July 13, 2026, Nu Skin Enterprises, Inc. (NUS) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. Nu Skin Enterprises, Inc. has a market capitalization of $281.11M, 48.55M shares outstanding, 179 institutional holders tracked. Key dilution vectors include approximately 108 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
39
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NUS.
🔔 Track NUS — Get forecast alerts →

💹 Market Data

Market Cap$281.11M
Shares Outstanding48.55M
Float47.35M
Cash$200.41M
Debt$223.59M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 13.2% shares (2026Q1 vs prior)
179 institutional holders · 42.59M shares
#1 BlackRock, Inc. 4.29M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 4.13M shares
#3 MORGAN STANLEY 3.20M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.80M
Days to Cover3.5
% of Float8.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2018
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NUS Shareholders

Nu Skin Enterprises, Inc. (NUS) has a DilutionScore of 23/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NUS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NUS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NUS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NUS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NUS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NUS
📊 NUS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NUS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.